Capacity of a horizontal subsurface flow constructed wetland system for the removal of emerging pollutants: An injection experiment

Chemosphere

Volumn 81, Issue 9, 2010, Pages 1137-1142

  Ávila, Cristina ^a,c   Pedescoll, Anna ^a   Matamoros, Víctor ^b   Bayona, Josep María ^c   García, Joan ^a  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b UNIVERSITY OF GIRONA   (Spain)

^c INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Bisphenol A; Constructed wetland; Emerging pollutant; Horizontal flow; Intermediate degradation products; Urban wastewater

Indexed keywords

BIODEGRADATION; DEGRADATION; DISSOLVED OXYGEN; PHENOLS; POLLUTION;

BIS-PHENOL A; CONSTRUCTED WETLANDS; EMERGING POLLUTANTS; HORIZONTAL FLOWS; INTERMEDIATE DEGRADATION PRODUCTS; URBAN WASTEWATER;

WETLANDS;

4,4' ISOPROPYLIDENEDIPHENOL; BROMIDE; DICLOFENAC; DISSOLVED OXYGEN; FRAGRANCE; IBUPROFEN; NAPROXEN; TONALIDE; UNCLASSIFIED DRUG;

BIODEGRADATION; CONSTRUCTED WETLAND; DRUG; HYDROPHOBICITY; PARTICULATE MATTER; PHENOLIC COMPOUND; POLLUTANT REMOVAL; SORPTION; SUBSURFACE FLOW; SUSPENDED LOAD; URBAN DRAINAGE; WASTEWATER;

ANAEROBIC METABOLISM; ARTICLE; BIODEGRADATION; CONCENTRATION (PARAMETERS); FLOW MEASUREMENT; HYDROPHOBICITY; OXYGEN CONCENTRATION; PARTICULATE MATTER; STEADY STATE; SUSPENDED PARTICULATE MATTER; WASTE WATER; WATER POLLUTANT; WATER QUALITY; WETLAND;

EID: 78049300380     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.08.006     Document Type: Article

References (28)

1. APHA., 2001. Standard Methods for the Examination of Water and Wastewater. 20th ed. American Public Health Association, Washington, DC, USA.
2. Carballa M., Omil F., Lema J.M., Llompart M., García-Jares C., Rodríguez I., Gómez M., Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38:2918-2926.
3. Carballa M., Omil F., Ternes T., Lema J.M., et al. Fate of pharmaceutical and personal care products (PPCPs) during anaerobic digestion of sewage sludge. Water Res. 2007, 41(10):2139-2150.
4. Cooper P.F., Job G.D., Green M.B., Shutes R.B.E. Reed Beds and Constructed wetlands for wastewater treatment 1996, WRc Swindon, UK, 184 pp.
5. Corzo, A., Pedescoll, A., Álvarez, E., García, J., 2008. Solids accumulation and drainable porosity in experimental subsurface flow constructed wetlands with different primary treatments and operating strategies. In: Proceedings 11th International Conference on Wetland Systems for Water Pollution Control. Indore, India. November 1-7.
6. Cunningham V.L., Buzby M., Hutchinson T., Mastrocco F., Parke N., Roden N. Effects of human pharmaceuticals on aquatic life: next steps. Environ. Sci. Technol. 2006, 40:3456-3462.
7. Daughton C.G. Non-regulated water contaminants: emerging research. Environ. Impact Assess. Rev. 2004, 24:711-732.
8. Dordio A.V., Estevao Candeias A.J., Pinto A.P., Teixeira da Costa C., Palace Carvalho A.J. Preliminary media screening for application in the removal of clofibric acid, carbamazepine and ibuprofen by SSF-constructed wetlands. Ecol. Eng. 2009, 35:290-302.
9. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
10. Gómez M., Garralón G., Plaza F., Vílchez R., Hontoria E., Gómez M.A. Rejection of endocrine disrupting compounds (bisphenol A, bisphenol F and triethyleneglycol dimethacrylate) by membrane technologies. Desalination 2007, 212:79-91.
11. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266:175-189.
12. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43:363-380.
13. Keri R.A., Ho S.-H., Hunt P.A., Knudsen K.E., Soto A.M., Prins G.S. An evaluation of evidence for the carcinogenic activity of bisphenol A. Reprod. Toxicol. 2007, 24:240-252.
14. Kimura K., Hara H., Watanabe Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 2005, 178:135-140.
15. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179:804-817.
16. Matamoros V., Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ. Sci. Technol. 2006, 40:5811-5816.
17. Matamoros V., Caselles-Osorio A., García J., Bayona J.M. Behavior of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetlands. A microcosm experiment. Sci. Total Environ. 2008, 394:171-176.
18. Matamoros V., García J., Bayona J.M. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environ. Sci. Technol. 2005, 39:5449-5454.
19. Puigagut J., Villaseñor J., Salas J.J., Bécares E., García J. Subsurface-flow constructed wetlands in Spain for the sanitation of small communities: a comparative study. Ecol. Eng. 2007, 30:312-319.
20. Quintana J.B., Weiss S., Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005, 39:2654-2664.
21. Rosal R., Rodríguez A., Perdigón-Melón J.A., Petre A., García-Calvo E., Gómez M.J., Agüera A., Fernández-Alba A.R. Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation. Water Res. 2010, 44:578-588.
22. Santos L.H.M.L.M., Araújo A.N., Fachini A., Pena A., Delerue-Matos C., Montenegro M.C.B.S.M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. J. Hazard. Mater. 2010, 175:45-95.
23. Schulz R., Peall S.K.C. Effectiveness of constructed wetland for retention of nonpoint-source pesticide pollution in the Lourens river catchment, South Africa. Environ. Sci. Technol. 2001, 35:422-426.
24. Schwarzenbach R.P., Gschwend P.M., Imboden D.M. Environmental Organic Chemistry 2003, Wiley-Interscience, New York, 1993. second ed.
25. Spivack J., Leib T.K., Lobos J.H. Novel pathways for bacterial metabolism of bisphenol A. J. Biol. Chem. 1994, 269:7323-7329.
26. Suarez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010, 44(10):3214-3224.
27. Wintgens T., Gallenkemper M., Melin T. Removal of endocrine disrupting compounds with membrane processes in wastewater treatment and reuse. Water Sci. Technol. 2004, 50(5):1-8.
28. Zwiener C., Frimmel F.H. Short-terms tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric compounds clofibric acid, ibuprofen, and diclofenac. Sci. Total Environ. 2003, 309:201-211.